SARAH PHILLIPS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TACOMA, WA NPI 1194377705

General Payments — all program years on this page

$414.34

  • Category: General Payments
  • Program years: PY2022–2023
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $391.05 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $391.0520

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $23.291
2023 $391.0520

Records — PY2023 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002923915 Novo Nordisk Inc $15.15 10/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002923929 Novo Nordisk Inc $19.80 09/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1004318617 GlaxoSmithKline, LLC. $16.32 08/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1009237963 ABBVIE INC. $23.33 09/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492069 Otsuka America Pharmaceutical, Inc. $12.84 05/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492073 Otsuka America Pharmaceutical, Inc. $19.84 07/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492077 Otsuka America Pharmaceutical, Inc. $14.26 08/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492081 Otsuka America Pharmaceutical, Inc. $21.97 09/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492085 Otsuka America Pharmaceutical, Inc. $23.49 10/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1015492089 Otsuka America Pharmaceutical, Inc. $17.50 11/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1021974329 UCB, Inc. $17.38 10/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1022895073 Alkermes, Inc. $20.28 10/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1022895075 Alkermes, Inc. $19.17 12/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032653533 Lundbeck LLC $16.24 11/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034002411 Astellas Pharma US Inc $19.74 03/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050284151 PFIZER INC. $21.38 10/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056985711 Teva Pharmaceuticals USA, Inc. $27.38 09/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056985733 Teva Pharmaceuticals USA, Inc. $20.57 11/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057231155 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.43 09/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057425857 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.98 04/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.